Marsha A Raebel

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. ncbi request reprint Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients
    Marsha A Raebel
    Kaiser Permannente Colorado Clinical Research Unit, Denver, 80237 8066, USA
    Pharmacotherapy 26:619-26. 2006
  2. ncbi request reprint Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237, USA
    Ann Pharmacother 41:193-200. 2007
  3. doi request reprint Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80237, USA
    Pharmacoepidemiol Drug Saf 19:19-25. 2010
  4. ncbi request reprint Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit, P O Box 378066, Denver, CO 80237 8066, USA
    J Manag Care Pharm 12:656-64. 2006
  5. pmc Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237, USA
    J Gen Intern Med 27:57-64. 2012
  6. pmc The positive predictive value of a hyperkalemia diagnosis in automated health care data
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 19:1204-8. 2010
  7. ncbi request reprint Monitoring of drugs with a narrow therapeutic range in ambulatory care
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente of Colorado, PO Box 378066, Denver, CO 80237 8066, USA
    Am J Manag Care 12:268-74. 2006
  8. ncbi request reprint Randomized trial to improve prescribing safety in ambulatory elderly patients
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, Colorado 80237 8066, USA
    J Am Geriatr Soc 55:977-85. 2007
  9. doi request reprint Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program
    Bharati Bhardwaja
    Pharmacy Department, Kaiser Permanente Colorado, Denver, Colorado 80011, USA
    Pharmacotherapy 31:346-56. 2011
  10. ncbi request reprint Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 16:55-64. 2007

Detail Information

Publications54

  1. ncbi request reprint Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients
    Marsha A Raebel
    Kaiser Permannente Colorado Clinical Research Unit, Denver, 80237 8066, USA
    Pharmacotherapy 26:619-26. 2006
    ..To determine whether an electronic tool effectively increases the percentage of patients receiving laboratory monitoring during ongoing drug therapy...
  2. ncbi request reprint Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237, USA
    Ann Pharmacother 41:193-200. 2007
    ..Serum potassium and creatinine evaluation is recommended in patients prescribed spironolactone, yet the proportion of ambulatory patients chronically dispensed spironolactone receiving evaluation is not well understood...
  3. doi request reprint Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80237, USA
    Pharmacoepidemiol Drug Saf 19:19-25. 2010
    ....
  4. ncbi request reprint Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit, P O Box 378066, Denver, CO 80237 8066, USA
    J Manag Care Pharm 12:656-64. 2006
    ..Amiodarone can cause liver and thyroid toxicity, but little is known about compliance with laboratory tests to evaluate liver and thyroid function among ambulatory patients who are dispensed amiodarone...
  5. pmc Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237, USA
    J Gen Intern Med 27:57-64. 2012
    ....
  6. pmc The positive predictive value of a hyperkalemia diagnosis in automated health care data
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 19:1204-8. 2010
    ..Our objectives were to determine performance of coded hyperkalemia diagnosis at identifying (1) clinically evident hyperkalemia and (2) serum potassium>6 mmol/L...
  7. ncbi request reprint Monitoring of drugs with a narrow therapeutic range in ambulatory care
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente of Colorado, PO Box 378066, Denver, CO 80237 8066, USA
    Am J Manag Care 12:268-74. 2006
    ....
  8. ncbi request reprint Randomized trial to improve prescribing safety in ambulatory elderly patients
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, Colorado 80237 8066, USA
    J Am Geriatr Soc 55:977-85. 2007
    ....
  9. doi request reprint Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program
    Bharati Bhardwaja
    Pharmacy Department, Kaiser Permanente Colorado, Denver, Colorado 80011, USA
    Pharmacotherapy 31:346-56. 2011
    ..To determine whether a computerized Drug Renal Alert Pharmacy (DRAP) program could decrease the rate of medication errors in drug selection or dosing for 15 target drugs in patients with renal insufficiency...
  10. ncbi request reprint Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80237 8066, USA
    Pharmacoepidemiol Drug Saf 16:55-64. 2007
    ..The purpose of this retrospective cohort study was to assess creatinine and potassium monitoring and characteristics associated with monitoring among patients dispensed ACEi or ARB...
  11. doi request reprint Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals
    Stanley Xu
    The Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80111, USA
    Value Health 13:273-7. 2010
    ..Currently, variance estimation requires additional work depending on type of outcomes. Our goal is to demonstrate a statistical approach to directly obtain appropriate estimates of variance of the main effects in regression models...
  12. doi request reprint Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit
    Elizabeth A Bayliss
    Institute for Health Research, Kaiser Permanente, Denver, CO, USA
    Med Care 48:267-72. 2010
    ..Medicare Part D beneficiaries who reach the drug benefit threshold (DBT) risk adverse health outcomes...
  13. ncbi request reprint Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente of Colorado, Denver, CO 80237 8066, USA
    Arch Intern Med 165:2395-401. 2005
    ..Opportunity exists to improve monitoring, with the potential to decrease therapy complications...
  14. pmc Diabetes and drug-associated hyperkalemia: effect of potassium monitoring
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80237, USA
    J Gen Intern Med 25:326-33. 2010
    ..Renin-angiotensin-aldosterone system (RAAS) inhibitors are associated with hyperkalemia, but there is little evidence demonstrating patients who receive potassium monitoring have a lower rate of hyperkalemia...
  15. doi request reprint Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns
    Cynthia L Hartsfield
    Kaiser Permanente, Denver, Colorado, USA
    Popul Health Manag 11:317-28. 2008
    ..Identifying patients with pDPN is a fundamental step for improving disease management and understanding the economic impact of pDPN...
  16. doi request reprint Importance of including early nonadherence in estimations of medication adherence
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, USA
    Ann Pharmacother 45:1053-60. 2011
    ..As a result, published studies may overestimate adherence, but the extent of overestimation posed by not considering patients with primary nonadherence and early nonpersistence has not been assessed...
  17. pmc Extension of Kaplan-Meier methods in observational studies with time-varying treatment
    Stanley Xu
    The Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80111, USA
    Value Health 15:167-74. 2012
    ..The objective of this research was to use adjusted Kaplan-Meier estimates and modified log-rank and Wilcoxon tests to examine the effect of a treatment that varies over time in an observational study...
  18. pmc Randomized trial to improve prescribing safety during pregnancy
    Marsha A Raebel
    Kaiser Permanente Colorado Clinical Research Unit, PO Box 378066, Denver, CO 80237 8066, USA
    J Am Med Inform Assoc 14:440-50. 2007
    ..S. Food and Drug Administration pregnancy risk category D or X medications was effective in decreasing dispensings of these medications...
  19. pmc Laboratory monitoring of drugs at initiation of therapy in ambulatory care
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit, Denver, CO 80237 8066, USA
    J Gen Intern Med 20:1120-6. 2005
    ..The objective of this study was to describe laboratory monitoring among ambulatory patients dispensed medications for which laboratory testing is recommended at therapy initiation...
  20. doi request reprint Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, Colorado 80237, USA
    Med Care 46:1116-22. 2008
    ..Information on the effects of reaching the Medicare Part D standard drug benefit threshold is limited...
  21. pmc Improving the validity of determining medication adherence from electronic health record medications orders
    Nikki M Carroll
    Kaiser Permanente Colorado, Institute for Health Research, Denver, Colorado 80237 8066, USA
    J Am Med Inform Assoc 18:717-20. 2011
    ..This work is an important first step to accurately identify study-specific patient adherence cohorts and allow more comprehensive estimates of population medication adherence...
  22. ncbi request reprint Meningococcal vaccine use in college students
    Julia A Kelleher
    Kaiser Permanente of Colorado, Denver, CO 80011, USA
    Ann Pharmacother 36:1776-84. 2002
    ..To discuss the role of meningococcal vaccine in prevention of meningococcal disease...
  23. ncbi request reprint Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus
    Karen J McConnell
    School of Pharmacy, University of Colorado Health Sciences Center, USA
    Pharmacotherapy 23:1564-72. 2003
    ....
  24. ncbi request reprint Compliance with dosing guidelines in patients with chronic kidney disease
    Charron L Long
    Kaiser Permanente of Colorado, PO Box 378066, Denver, CO 80237 8066, USA
    Ann Pharmacother 38:853-8. 2004
    ..To assess the level of reported compliance with renal dosing guidelines in inpatient, long-term care, and ambulatory settings...
  25. ncbi request reprint Health services use and health care costs of obese and nonobese individuals
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente of Colorado, Denver, CO 80237, USA
    Arch Intern Med 164:2135-40. 2004
    ..Obesity has clinical and economic consequences. Few studies have compared health care resource utilization between age- and sex-matched obese and nonobese persons...
  26. ncbi request reprint Interventions to improve treatment of respiratory infections in ambulatory managed-care patients
    Marsha A Raebel
    Kaiser Permanente of Colorado, Clinical Research Unit, Denver, CO 80237 8066, USA
    Ann Pharmacother 39:699-705. 2005
    ....
  27. ncbi request reprint Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data
    Marsha A Raebel
    HMO Research Network, Center for Education and Research on Therapeutics CERTs, Denver, CO, USA
    Pharmacoepidemiol Drug Saf 14:829-36. 2005
    ..Our aim was to evaluate the 270-day gestational age and delivery date assumptions used in an administrative dataset study assessing prenatal drug exposure compared to information contained in a birth registry...
  28. ncbi request reprint Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy
    Robert L Davis
    Center for Health Studies, Group Health Cooperative, Seattle, WA, USA
    Pharmacoepidemiol Drug Saf 16:1086-94. 2007
    ..To evaluate risks for perinatal complications and congenital defects among infants exposed in utero to antidepressants...
  29. ncbi request reprint Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients
    Marsha A Raebel
    Kaiser Permanente of Colorado Clinical Research Unit and School of Pharmacy, University of Colorado at Denver, 80237, USA
    Ann Pharmacother 40:386-91. 2006
    ..Allopurinol dosage reduction is recommended in patients with renal dysfunction because drug toxicity risk is increased. Little information is available about serum creatinine (SCr) monitoring in ambulatory patients taking allopurinol...
  30. ncbi request reprint Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy
    Marsha A Raebel
    Clinical Research Unit, Kaiser Permanente of Colorado, and the School of Pharmacy, University of Colorado, Denver, Colorado 80237 8066, USA
    Pharmacotherapy 25:1055-61. 2005
    ..To determine the frequency of monitoring of international normalized ratio (INR) within 14 days of coprescription of warfarin and antimicrobial therapy and to evaluate differences in INR monitoring among antimicrobials...
  31. pmc Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy
    Robert L Davis
    Center for Health Research, Kaiser Permanente Georgia, Southeast, Atlanta, Georgia 30305, USA
    Pharmacoepidemiol Drug Saf 20:138-45. 2011
    ..We used population-based data from 5 HMOs to study risks for perinatal complications and congenital defects among infants exposed in-utero...
  32. doi request reprint Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Marsha A Raebel
    Institute for Health Research, Kaiser Permanente Colorado, Denver, CO 80237, USA
    Cardiovasc Ther 30:e156-66. 2012
    ..Should hyperkalemia occur, prompt recognition and management can optimize clinical outcome...
  33. ncbi request reprint Pharmaceuticals from development to practice: learnings from an online curriculum
    David W Price
    Kaiser Permanente Institute for Health Research, 10065 E Harvard Ave, Ste 300, Denver, CO 80231, USA
    Am J Manag Care 15:e109-14. 2009
    ..To report outcomes of a pilot online curriculum educating clinicians about off-label prescribing, finding unbiased sources of pharmaceutical information, and responding to patient inquiries about direct-to-consumer advertised medications...
  34. pmc Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, CO 80231, USA
    Med Care 51:S11-21. 2013
    ....
  35. ncbi request reprint Prescription drug use in pregnancy
    Susan E Andrade
    Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
    Am J Obstet Gynecol 191:398-407. 2004
    ..The purpose of this study was to provide information on the prevalence of the use of prescription drugs among pregnant women in the United States...
  36. doi request reprint Outpatient use of cardiovascular drugs during pregnancy
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 17:240-7. 2008
    ..To provide information on the prevalence of use of cardiovascular drugs, some of which may have fetotoxic or teratogenic effects, in the outpatient setting among pregnant women in the United States...
  37. ncbi request reprint Chronic disease score as a predictor of hospitalization
    Kathleen G Putnam
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Epidemiology 13:340-6. 2002
    ..We compared four versions of the score for their ability to predict hospitalization among members of eight health maintenance organizations nationwide...
  38. ncbi request reprint The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization
    Julie A Porter
    Aventis Pharmaceuticals, Inc, Bridgewater, NJ 08807, USA
    Am J Manag Care 10:369-76. 2004
    ..To assess the benefit of sibutramine hydrochloride monohydrate within a weight management program...
  39. ncbi request reprint Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States
    Christopher J Stille
    HMO Research Network Center for Education and Research on Therapeutics, University of Massachusetts Medical School, Worcester, MA 01655, USA
    Pediatrics 114:1206-11. 2004
    ....
  40. ncbi request reprint Cost-effectiveness of sibutramine in the LOSE Weight Study: evaluating the role of pharmacologic weight-loss therapy within a weight management program
    Daniel C Malone
    University of Arizona College of Pharmacy, PO Box 210207, Tucson, AZ 85721, USA
    J Manag Care Pharm 11:458-68. 2005
    ..The core WMP was a physician-supervised, multidisciplinary program for which each enrollee paid $100 out of pocket...
  41. ncbi request reprint Frequency of high-risk use of QT-prolonging medications
    Nancy M Allen LaPointe
    Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
    Pharmacoepidemiol Drug Saf 15:361-8. 2006
    ..Concurrent use of more than one QT-prolonging drug or a QT-prolonging drug with a drug that alters its pharmacokinetic profile is an important risk factor for adverse outcomes...
  42. ncbi request reprint FDA drug prescribing warnings: is the black box half empty or half full?
    Anita K Wagner
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA 02215, USA
    Pharmacoepidemiol Drug Saf 15:369-86. 2006
    ..The purpose of the present study was to assess the frequency of use of BBW medications in ambulatory care and prescribing compliance with BBW recommendations...
  43. ncbi request reprint Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees
    Steven R Simon
    HMO Research Network Center for Education and Research in Therapeutics and Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    J Am Geriatr Soc 53:2165-9. 2005
    ..To identify correlates of laboratory monitoring errors in elderly health maintenance organization (HMO) members at the initiation of therapy with cardiovascular medications...
  44. ncbi request reprint Potential drug-drug interactions in the outpatient setting
    Jennifer Elston Lafata
    Henry Ford Health System, Detroit, Michigan 48202, Channing Laboratory, Brigham and Women s Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
    Med Care 44:534-41. 2006
    ..Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern...
  45. ncbi request reprint Use of antidepressant medications during pregnancy: a multisite study
    Susan E Andrade
    Meyers Primary Care Institute, Worcester, MA 01605, USA
    Am J Obstet Gynecol 198:194.e1-5. 2008
    ..This study was undertaken to provide information on the prevalence of use of antidepressant drugs among pregnant women in the United States...
  46. ncbi request reprint Improved therapeutic monitoring with several interventions: a randomized trial
    Adrianne C Feldstein
    Center for Health Research, Kaiser Permanente, Portland, OR, USA
    Arch Intern Med 166:1848-54. 2006
    ..Differences between guideline recommendations and actual frequency of therapeutic laboratory monitoring are substantial. This study evaluated interventions to improve laboratory monitoring at initiation of medication therapy...
  47. ncbi request reprint Validity of gout diagnoses in administrative data
    Leslie R Harrold
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, Worcester, Massachusetts 01655, USA
    Arthritis Rheum 57:103-8. 2007
    ..To determine the utility of using administrative data for epidemiologic studies of gout by examining the validity of gout diagnoses in claims data...
  48. ncbi request reprint What do medical records tell us about potentially harmful co-prescribing?
    Jennifer Elston Lafata
    Center for Health Services Research, Henrry Ford Health System, Detroit, USA
    Jt Comm J Qual Patient Saf 33:395-400. 2007
    ..Previous efforts document drug-drug interactions in ambulatory care. Yet little is known about medical record documentation or clinical management when interacting medications are received...
  49. ncbi request reprint Use of prescription medications with a potential for fetal harm among pregnant women
    Susan E Andrade
    Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
    Pharmacoepidemiol Drug Saf 15:546-54. 2006
    ..To estimate the prevalence of use of prescription drugs with a potential for fetal harm among pregnant women in the United States...
  50. ncbi request reprint Reduction in antibiotic use among US children, 1996-2000
    Jonathan A Finkelstein
    HMO Research Network Centers for Education and Research on Therapeutics Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts 02215, USA
    Pediatrics 112:620-7. 2003
    ..The Centers for Disease Control and Prevention, in collaboration with other national and state level organizations, have actively promoted more judicious prescribing for children...
  51. ncbi request reprint Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans
    Kathleen M Mazor
    Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation, and Fallon Community Health Plan, Worcester, Massachusetts, USA
    Med Care 45:S29-37. 2007
    ....
  52. ncbi request reprint Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists
    Karim Anton Calis
    Pharmacotherapy 24:1241-94. 2004
  53. ncbi request reprint Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures
    Lisa M Hess
    Arizona Cancer Center, University of Arizona, Tucson, 85724, USA
    Ann Pharmacother 40:1280-88. 2006
    ..These measures have focused on improving the accuracy of adherence measures or clarifying the evaluation time frame. As a result, there are many measures used to assess adherence that may or may not be comparable or accurate...
  54. ncbi request reprint Early detection of adverse drug events within population-based health networks: application of sequential testing methods
    Jeffrey S Brown
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 16:1275-84. 2007
    ....